One of the biggest headlines in the healthcare arena on Tuesday was that GlaxoSmithKline Plc, has agreed to purchase Novartis AG’s stake in their consumer-health joint venture for $13 billion. GlaxoSmithKline, which is the U.K.’s biggest drugmaker, has decided to make the purchase instead of bidding for a Pfizer Inc. unit. According to the company’s … Continue reading “GlaxoSmithKline to Buy Novartis AG’s Stake in Consumer-Health Joint Venture for $13B”
